PlexusDx patients can access Precision Peptide Genetic Testing to identify individual predispositions in glucose metabolism pathways, allowing providers to anticipate and prevent metabolic complications
Potential metabolic shifts
The relationship between tirzepatide and menstrual irregularities is primarily indirect, mediated through significant weight loss and metabolic improvements
This result indicates that PUF-8 and its repressing target, GLD-2, genetically work together to inhibit the formation of proximal germline tumors
Conclusions The findings of the present study revealed that the treatment of Chinese patients with T2D with tirzepatide yields a PK/PD profile consistent with that reported in previous studies, with efficacy for glycemic control and body weight reduction, as well as a favorable safety profile
The overall evidence supports a favorable hepatic safety profile, with potential therapeutic benefits for patients with underlying liver disease related to metabolic syndrome